Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia

Observational study about the prophylactic effect and the security of Curmeric in COVID- 19 administered to the health workers in the University Hospital General Calixto Garcia. (COVID-19)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

RPCEC

Registry ID

RPCEC00000344

Enrollment

199

Registered

2020-11-24

Start date

2020-03-19

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 COVID-19 SARS-CoV2

Interventions

Group I, Curmeric. Natural product with Curcuma longa extracts- intellectual property under request-(oral) 4mL gargars/mouth wash after main meals for 1 month. Group II, No intervention In the study

Curcuma

Administration, Oral

Plant Extracts

mouthwashes, gargles

Eligibility

Sex/Gender

All

Age

19 Years to 85 Years

Inclusion criteria

Inclusion criteria: Workers of the University Hospital General Calixto Garcia form the departments/services of first and second level of exposition to the patients with respiratory diseases and presencial work.

Exclusion criteria

Exclusion criteria: Known allergy to turmeric

Design outcomes

Primary

Measure	Time frame
Patient confirmed with COVID-19 (Yes, No). Measurement time: 1 month	—

Secondary

Measure	Time frame
Adverse Events-AE (Occurrence of AE (Yes, No); Type of event (name of AE); Intensity of AE (Mild, Moderate, Severe); Result (Recovered, Not recovered, Recovered with sequelae, Death); Required treatment (Yes, No)). Measurement time: 1 month	—

Countries

Cuba

Contacts

Public ContactTania Valdes Gonzalez

Center for Technological Applications and Nuclear Development (CEADEN)

taniajapon@gmail.com

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Apr 4, 2026